Algernon Pharmaceuticals Inc (AGNPF)

[J0987654321]

My, grandfather was very wise. Unlike most he was a philosopher and his name was socrates....


PAYTIENCE IS A VIRTUE.

AND THOSE THAT DONT HAVE THIS VIRTUE WILL MISS OUT ON QUITE A FORTUNE. REAL COMPANY, FIGHTING AN ENORMOUS ISSUE AND I MYSELF CAN ATTEST THAT THE PROBLEMS THEY ARE TRYING TO TREAT. THEY ARE REAL AND ARE CAUSING INSUES IN THOUSANDS UPON THOUSANDS OF PEOPLE THROUGHOUT THE WORLD.

I hope that the wait is only a good sign for the sake of the world because this company targets real issues.
I had covid back in December, and the long-term effects have been detrimental to my health and work. As a starting point, my ability to stay focused has dramatically decreased. For example, when writing and speaking, I begin to experience memory slippage. Additionally, it has become harder to breathe; one moment, I may be fine, and in the next, I feel as if I'm gasping or trying much harder to breathe. Now, this may be very confounding, but ever since I was a kid, I would go over to my friend's house, and we would hang out in their basement where their dog lives. I have known GGie, the dog, since they picked her up from the kennel 17 years ago. Approximately three weeks ago, I had to stop going over to their house because suddenly, I developed an allergy to dogs. If I go over to their house, I uncontrollably sneeze, which continues for 2-3 hours after leaving their home. Now I understand my allergy may not have been causing by covid, but there are way too many unexplainable issues that I am having, for example, stomach problems. I hope that this company will lead change in the pharmaceutical industry and start producing treatment remedies because our focus has been on prevention. Prevention comes at a cost because millions of people are experiencing unexplained side effects that doctors and pharmaceutical companies cannot explain. Companies like this are going to change our battle with covid and benefit hundreds of thousands of people. I look forward to reading and studying the results and efficacy of trial 2b.